Related Experiment Video
Updated: Sep 24, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
Published on: July 3, 2020
Classical and Bayesian Inference Using Type-II Unified Progressive Hybrid Censored Samples for Pareto Model
M Nagy1, Adel Fahad Alrasheedi1
1Department of Statistics and Operations Research, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
This study introduces the Type-II unified progressive hybrid censored sample for reliability experiments. It applies this method to estimate Pareto distribution parameters using maximum likelihood and Bayesian approaches, demonstrating its practical applicability.
Area of Science:
- Statistics
- Reliability Engineering
- Survival Analysis
Background:
- Censored samples are crucial in lifetime and reliability experiments for cost and time efficiency.
- Traditional methods face challenges, leading to the development of advanced censored sample schemes.
- The Type-II unified progressive hybrid censored sample (T-II UPHCS) was recently proposed by Górny and Cramer (2018).
Purpose of the Study:
- To provide an overview of the Type-II unified progressive hybrid censored sample.
- To utilize T-II UPHCS for estimating unknown parameters of the Pareto distribution.
- To compare different estimation techniques, including maximum likelihood and Bayesian methods.
Main Methods:
- Application of Type-II unified progressive hybrid censored sampling.
- Computation of maximum likelihood estimates (MLEs) for Pareto distribution parameters.
- Derivation of Bayesian estimates under three distinct error loss functions.
- Development of one- and two-sample Bayesian predictive intervals.
- Conducting simulation studies for performance comparison.
- Analysis of real-world datasets to validate the model and methods.
Main Results:
- The study successfully applies T-II UPHCS to Pareto distribution parameter estimation.
- Both MLE and Bayesian approaches are investigated, offering a comprehensive analysis.
- Bayesian predictions (point and interval) are derived and presented.
- Simulation results provide insights into the comparative performance of different inference strategies.
- Real data analysis confirms the practical utility of the proposed censored sampling scheme and estimation techniques.
Conclusions:
- The Type-II unified progressive hybrid censored sample is a valuable tool for reliability studies.
- The presented estimation methods, particularly Bayesian approaches, offer robust parameter estimation and prediction for the Pareto distribution.
- The study validates the applicability and effectiveness of the T-II UPHCS in real-world scenarios.
Related Concept Videos
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Censoring Survival Data
Distributions to Estimate Population Parameter
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

